News

Riddhi Siddhi Gluco Biols announced that the Board of Directors of the Company at its meeting held on 25 May 2026, inter alia, have recommended the final dividend of Rs 3 per equity Share (i.e. 30%) , subject to the approval of the shareholders.

Net loss of Riddhi Siddhi Gluco Biols reported to Rs 32.54 crore in the quarter ended March 2026 as against net profit of Rs 3.63 crore during the previous quarter ended March 2025. Sales declined 67.70% to Rs 9.05 crore in the quarter ended March 2026 as against Rs 28.02 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 12.71 crore in the year ended March 2026 as against net profit of Rs 5.20 crore during the previous year ended March 2025. Sales rose 74.04% to Rs 235.84 crore in the year ended March 2026 as against Rs 135.51 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales9.0528.02 -68 235.84135.51 74 OPM %-89.06-12.31 --5.211.47 - PBDT-1.5420.13 PL 38.7780.01 -52 PBT-3.5817.99 PL 30.5471.48 -57 NP-32.543.63 PL -12.715.20 PL Powered by Capital Market - Live News

Riddhi Siddhi Gluco Biols will hold a meeting of the Board of Directors of the Company on 19 May 2026.

Net Loss of Riddhi Siddhi Gluco Biols reported to Rs 1.59 crore in the quarter ended December 2025 as against net loss of Rs 36.05 crore during the previous quarter ended December 2024. Sales declined 9.59% to Rs 40.08 crore in the quarter ended December 2025 as against Rs 44.33 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales40.0844.33 -10 OPM %-13.77-1.71 - PBDT4.5816.95 -73 PBT2.5014.80 -83 NP-1.59-36.05 96 Powered by Capital Market - Live News

Riddhi Siddhi Gluco Biols will hold a meeting of the Board of Directors of the Company on 7 February 2026.Powered by Capital Market - Live News